Endometriosis Trial, Recruiting (NCT06333353)

Endometriosis Trial, Recruiting NCT06333353 Sponsor: University of Ottawa Condition: Endometriosis

Printed from Voxsanity (voxsanity.com.au) — NCT06333353 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Endometriosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have endometriosis-related pain that you would rate more than 3 out of 10, and this pain has continued even after trying medical treatments or surgery

Who may not be able to join:

You have metal implants or devices in or around your head or neck (such as a pacemaker), or there are other reasons you cannot have repetitive transcranial magnetic stimulation (a type of non-invasive brain stimulation) — (confirm with trial site)
You or a family member has a history of epilepsy or seizures
Your pain is known to be caused by something other than endometriosis, such as an infection, thyroid condition, autoimmune disease, or digestive/gut disease
You have pain outside the pelvic area that is more severe than your endometriosis-related pain
You are currently pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Linda McLean, PhD, University of Ottawa

Phone: 613-562-5800

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06333353

Sponsor: University of Ottawa

Phase: Not Applicable

Status: Recruiting

Condition: Endometriosis

Trial contact: 613-562-5800

More information: https://clinicaltrials.gov/study/NCT06333353

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have endometriosis-related pain that you would rate more than 3 out of 10, and this pain has continued even after trying medical treatments or surgery

Who may not be able to join:

You have metal implants or devices in or around your head or neck (such as a pacemaker), or there are other reasons you cannot have repetitive transcranial magnetic stimulation (a type of non-invasive brain stimulation) — (confirm with trial site)
You or a family member has a history of epilepsy or seizures
Your pain is known to be caused by something other than endometriosis, such as an infection, thyroid condition, autoimmune disease, or digestive/gut disease
You have pain outside the pelvic area that is more severe than your endometriosis-related pain
You are currently pregnant

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Ottawa

Registry

ClinicalTrials.gov

Start date

12 April 2024

Est. completion

20 May 2027

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Numeric rating scale (NRS) used to record daily pain over 30 days; Numeric rating scale(NRS) used to record daily pain over 30 days; Patient Global Impression of Change (PGIC) in pain; Patient Global Impression of Change (PGIC) in pain; Patient Global Impression of Change (PGIC) in pain

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov